HK1093197A1 - Meldonium salts, method of their preparation and pharmaceutical composition on their basis - Google Patents

Meldonium salts, method of their preparation and pharmaceutical composition on their basis

Info

Publication number
HK1093197A1
HK1093197A1 HK06113946.2A HK06113946A HK1093197A1 HK 1093197 A1 HK1093197 A1 HK 1093197A1 HK 06113946 A HK06113946 A HK 06113946A HK 1093197 A1 HK1093197 A1 HK 1093197A1
Authority
HK
Hong Kong
Prior art keywords
salts
sup
acid
meldonium
basis
Prior art date
Application number
HK06113946.2A
Other languages
English (en)
Inventor
Ivars Kalvinsh
Anatolijs Birmans
Original Assignee
Joint Stock Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LV030088A external-priority patent/LV13280B/lv
Priority claimed from LV030087A external-priority patent/LV13279B/lv
Application filed by Joint Stock Company filed Critical Joint Stock Company
Publication of HK1093197A1 publication Critical patent/HK1093197A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10—Hydrazines
    • C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10—Hydrazines
    • C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
    • C07C243/14—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/16—Halogenated acetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/06—Oxalic acid
    • C07C55/07—Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/10—Succinic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/14—Adipic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/145—Maleic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/08—Lactic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK06113946.2A 2003-08-04 2006-12-19 Meldonium salts, method of their preparation and pharmaceutical composition on their basis HK1093197A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
LV030088A LV13280B (en) 2003-08-04 2003-08-04 Sustained release salts of 3-(2,2,2-trimethylhydrazinium)propionate, a method of production and pharmaceutical compositions thereof
LV030087A LV13279B (en) 2003-08-04 2003-08-04 Non-hygroscopic salts of 3-(2,2,2-trimethylhydrazinum)propionate,a method of production and pharmaceutical compositions thereof
PCT/LV2004/000005 WO2005012233A1 (en) 2003-08-04 2004-07-15 Meldonium salts, method of their preparation and pharmaceutical composition on their basis

Publications (1)

Publication Number Publication Date
HK1093197A1 true HK1093197A1 (en) 2007-02-23

Family

ID=34118016

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06113946.2A HK1093197A1 (en) 2003-08-04 2006-12-19 Meldonium salts, method of their preparation and pharmaceutical composition on their basis

Country Status (23)

Country Link
US (1) US7223797B2 (de)
EP (1) EP1667960B1 (de)
JP (1) JP4634380B2 (de)
KR (1) KR100745160B1 (de)
AT (1) ATE386014T1 (de)
AU (1) AU2004260779B2 (de)
CA (1) CA2535150C (de)
DE (1) DE602004011790T2 (de)
DK (1) DK1667960T3 (de)
EA (1) EA009083B1 (de)
ES (1) ES2302011T3 (de)
HK (1) HK1093197A1 (de)
HR (1) HRP20080192T3 (de)
IL (1) IL173126A (de)
MA (1) MA28025A1 (de)
MX (1) MXPA06000955A (de)
NO (1) NO334623B1 (de)
NZ (1) NZ545440A (de)
PL (1) PL1667960T3 (de)
PT (1) PT1667960E (de)
SI (1) SI1667960T1 (de)
UA (1) UA82540C2 (de)
WO (1) WO2005012233A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV13450B (en) * 2004-08-24 2006-11-20 Grindeks As Novel medicinal use of meldonium and pharmaceutical compositions thereof
US10183001B1 (en) * 2007-05-22 2019-01-22 Pisgah Laboratories, Inc. Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
TW200930356A (en) * 2007-12-04 2009-07-16 Grindeks Jsc New medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts
TWI391131B (zh) * 2007-12-05 2013-04-01 Grindeks Jsc ３－（２，２，２－三甲基肼）丙酸鹽的新用途
EP2067473A3 (de) * 2007-12-05 2009-09-09 Grindeks, a joint stock company Medizinische Verwendung von 3-(2,2,2-Trimethylhydrazinium)propionat-Salzen
EP2067474A1 (de) * 2007-12-05 2009-06-10 Grindeks, a joint stock company Neue medizinische Verwendung von 3-(2,2,2-Trimethylhydrazinium)propionat-Salz
WO2009074498A1 (en) * 2007-12-12 2009-06-18 Grindeks Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate
WO2009095445A1 (en) * 2008-01-29 2009-08-06 Grindeks New second medical use of 3-(2,2,2-trimethylhydrazine)propionate dihydrate
EA016355B1 (ru) * 2008-02-19 2012-04-30 Гриндекс, Джоинт Сток Кампани Одностадийный способ получения дигидрата 3-(2,2,2-триметилгидразиниум)пропионата
CN102036950B (zh) * 2008-05-26 2013-10-09 格林代克斯联合股份公司 制备3-(2，2，2-三甲基肼)丙酸盐二水合物的新方法
EP2128126A1 (de) * 2008-05-26 2009-12-02 Grindeks, a joint stock company Neues Verfahren zur Herstellung von 3-(2,2,2-Trimethylhydrazinium) Propionat-Dihydrat
CN102202651A (zh) * 2008-10-29 2011-09-28 格林代克斯联合股份公司 3-(2,2,2-三甲基肼)丙酸盐二水合物的外用制剂
LV14230B (lv) * 2009-04-30 2011-05-20 Latvijas Organiskās Sintēzes Institūts Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai
LV14268B (lv) * 2009-06-25 2011-03-20 Grindeks, A/S Meldonija sukcinātu saturoši medicīniskie produkti
LV14274B (lv) * 2009-06-25 2011-03-20 Grindeks, A/S Meldoniju saturošs kombinēts medicīniskais produkts
WO2010149654A1 (en) * 2009-06-25 2010-12-29 Grindeks, A Joint Stock Company Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt
WO2010151095A1 (en) * 2009-06-25 2010-12-29 Tetra, Sia Novel acetylsalicylic acid salts
EP2399904A1 (de) * 2010-05-26 2011-12-28 Nabriva Therapeutics AG Verfahren zur Herstellung von Pleuromutilinen
EP2420224A1 (de) * 2010-08-11 2012-02-22 Grindeks, a joint stock company Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung aus stabilem 3-(2,2,2-trimethylhydrazinium)propionatdihydrat
BR112013027065B1 (pt) * 2011-04-27 2019-12-03 Grindeks Jsc processo para a preparação de sais de 3-carboxi-n-etil-n,n-dimetilpropan-1amínio, compostos e seus usos
RU2458690C1 (ru) * 2011-05-31 2012-08-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-бромникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее противоишемической активностью
RU2457198C1 (ru) * 2011-05-31 2012-07-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее противоишемической активностью
RU2467745C1 (ru) * 2011-08-08 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-бромникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее эндотелиопротекторной активностью
RU2467744C1 (ru) * 2011-08-08 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-гидрокисиникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее эндотелиопротекторной активностью
RU2485953C1 (ru) * 2012-04-12 2013-06-27 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Комплекс 3-(2,2,2-триметилгидразиний) пропионат-2-этил-6-метил-3-гидроксипиридина дисукцинат, обладающий антигипоксическим и адаптогенным действием, и способ его получения
LV14848B (lv) * 2012-10-25 2015-06-20 Latvijas Organiskās Sintēzes Institūts Farmaceitiska kompozīcija trimetilamīna-N-oksīda līmeņa pazemināšanai
RU2527347C1 (ru) * 2013-03-12 2014-08-27 Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита" Стабильная жидкая фармацевтическая композиция комплекса 3-(2,2,2-триметилгидразиний) пропионат-2-этил-6-метил-3-гидроксипиридина дисукцината, обладающая антигипоксическим, антиоксидантным и адаптогенным действием
EP2842557A1 (de) * 2013-08-30 2015-03-04 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Mildronat bei Augenerkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU997646A1 (ru) * 1978-11-27 1983-02-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Кормова добавка
SU978808A1 (ru) * 1980-01-18 1982-12-07 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Способ регулировани роста растений люпина
SU1680693A1 (ru) * 1987-03-25 1991-09-30 Институт Органического Синтеза Ан Латвсср Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность
EP0307977B1 (de) 1987-09-07 1992-09-30 Teikoku Tsushin Kogyo Co. Ltd. Gehäuse aus vergossenem Kunststoff für einen elektronischen Teil mit flachem Kabel
LV11727B (en) 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition

Also Published As

Publication number Publication date
WO2005012233A8 (en) 2005-05-19
KR20060059995A (ko) 2006-06-02
CA2535150C (en) 2010-04-13
HRP20080192T3 (en) 2008-05-31
US7223797B2 (en) 2007-05-29
PT1667960E (pt) 2008-05-02
NZ545440A (en) 2009-03-31
US20060264506A1 (en) 2006-11-23
ATE386014T1 (de) 2008-03-15
AU2004260779A1 (en) 2005-02-10
NO334623B1 (no) 2014-04-28
DE602004011790D1 (de) 2008-03-27
DK1667960T3 (da) 2008-06-09
EA200600175A1 (ru) 2006-08-25
MXPA06000955A (es) 2006-03-30
EP1667960B1 (de) 2008-02-13
DE602004011790T2 (de) 2009-03-05
MA28025A1 (fr) 2006-07-03
IL173126A (en) 2011-02-28
EP1667960A1 (de) 2006-06-14
ES2302011T3 (es) 2008-07-01
JP2007501222A (ja) 2007-01-25
EA009083B1 (ru) 2007-10-26
JP4634380B2 (ja) 2011-02-16
AU2004260779B2 (en) 2009-01-22
IL173126A0 (en) 2006-06-11
CA2535150A1 (en) 2005-02-10
PL1667960T3 (pl) 2008-06-30
NO20055867L (no) 2006-02-27
SI1667960T1 (sl) 2008-08-31
UA82540C2 (uk) 2008-04-25
WO2005012233A1 (en) 2005-02-10
KR100745160B1 (ko) 2007-08-01

Similar Documents

Publication Publication Date Title
IL173126A0 (en) Meldonium salts, method of their preparation and pharmaceutical composition on their basis
RU2213089C2 (ru) Моноциклические бензамиды производных 3- или 4-замещенного 4-(аминометил)пиперидина, способы их получения, фармацевтическая композиция, способ ее приготовления, производное карбоновой кислоты
HK1051683A1 (en) N-heterocyclic derivatives as nos inhibitors
HUP0100615A2 (hu) Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére
HUP0102723A2 (hu) Új difenilkarbamid-származékok, eljárás előállításukra és ezeket tartalmazó gyógyászati készítmények
WO2004082581A3 (fr) Application a titre de medicaments de derives de cholest-4-en-3- one, compositions pharmaceutiques les renfermant et nouveaux derives
HUT57740A (en) Process for producing n-arylpiperazine alkaneamide derivatives of general formula (i) and pharmaceutical compositions promoting sleep and comprising such compounds
AU1812795A (en) Novel amino acid derivatives, method of producing them and pharmaceutical compositions containing these compounds
JPH08510477A (ja) 新規なｎ−ベンゾイルメチル−ピペリジン類
AU2002218422A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
HK1075656A1 (en) New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
NO20041551L (no) Substituerte alkylaminopyridazinonderivater, fremgangsmate til fremstilling derav og farmasoytisk sammensetning som inneholder dem
EP1195377A4 (de) Diester der malein- und fumarsäure
WO2001083457A3 (en) Benzimidazole-2-carbamates and their use in cancer treatment
JPH09502200A (ja) インドリジン誘導体の製造法
IS7034A (is) Díhýdróimidazó [5,1-A-] -SG(b)-karbólínafleiður, aðferð til framleiðslu þeirra og notkun sem lyf
GB0114699D0 (en) Organic compounds
HU196159B (en) Process for producing aphidicolin derivatives and pharmaceutics comprising the same as active ingredient
JPH05271220A (ja) アミン誘導体およびこれを含有する降圧剤
NO20022891L (no) Nye cykliske <alfa>-amino-<gamma>-hydroksyamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetningerinneholdende dem
YU82302A (sh) Derivati 2-aminokarbonil-9h-purina

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140715